Oneness Biotech Co., Ltd. (4743)
TWSE
49.25
+1.15 (+2.39%)
Closed
Oct 12, 2026
Day's Range
48.2050.10
52 wk Range
40.8076.70
Financial Statements - 4743 - Oneness Biotech Co., Ltd.
Revenue
129.12M▲ 9.5%
Net Income
-1.05B▲ 8.1%Net Margin -820.6%
EBITDA
-713.39M▼ 4.0%
Free Cash Flow
-486.73M▼ 22.0%
Income Statement
| Period Ending | 2025-12-31 | 2024-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 | 2019-12-31 |
|---|---|---|---|---|---|---|
| Sales | 129.12M | 117.92M | 1.06B | 65.76M | 41.60M | 13.47M |
| Cost of Goods | 89.24M | 54.89M | 221.16M | 20.72M | 10.88M | 17M |
| Gross Profit | 39.87M | 63.03M | 844.39M | 45.04M | 30.71M | -3.52M |
 Operating Expense | - | - | - | - | - | - |
| Operating Income | -799.07M | -1.08B | -241.44M | -878.13M | -666.11M | -311.73M |
| Non-Operating Interest | - | - | - | - | - | - |
| Other Income Expense | - | - | - | - | - | - |
| Pre Tax Income | -1.05B | -1.14B | 451.62M | -395.96M | -249.94M | -326.26M |
| Income Tax | 3.46M | 3.28M | 99.73M | 16.86M | 1.73M | 0 |
| Net Income | -1.05B | -1.15B | 351.89M | -412.82M | -251.67M | -326.26M |
| EPS Basic | -2.18 | -2.44 | 0.775268 | -0.883639 | -0.566863 | -1.067036 |
| EPS Diluted | -2.18 | -2.44 | 0.758596 | -0.883639 | -0.566863 | -1.067036 |
| Basic Shares Outstanding | 479.39M | 478.18M | 465.48M | 457.27M | 428.08M | 301.27M |
| Diluted Shares Outstanding | 479.39M | 478.18M | 465.48M | 457.27M | 428.08M | 301.27M |
| Ebit | -1.04B | -1.14B | 456.22M | -391.06M | -244.76M | -320M |
| Ebitda | -713.39M | -685.70M | 950.86M | -193.72M | -52.14M | -253.86M |
| Net Income Continuous Operations | -1.05B | -1.14B | 451.62M | -395.96M | -249.94M | -326.26M |
| Minority Interests | 14.75M | -12.12M | 8.07M | 9.52M | 9.77M | 4.05M |
| Preferred Stock Dividends | 0 | 0 | 0 | 0 | 0 | 0 |
The information on this page is provided for general informational purposes only and is not investment advice.
Market data provided by Twelve Data. Charting by TradingView.
Last updated:
